[go: up one dir, main page]

BR9611511A - Derivados de aminoácidos excitatórios - Google Patents

Derivados de aminoácidos excitatórios

Info

Publication number
BR9611511A
BR9611511A BR9611511A BR9611511A BR9611511A BR 9611511 A BR9611511 A BR 9611511A BR 9611511 A BR9611511 A BR 9611511A BR 9611511 A BR9611511 A BR 9611511A BR 9611511 A BR9611511 A BR 9611511A
Authority
BR
Brazil
Prior art keywords
amino acid
acid derivatives
excitatory amino
excitatory
derivatives
Prior art date
Application number
BR9611511A
Other languages
English (en)
Inventor
Steven Marc Massey
James Allen Monn
Matthew John Valli
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605434.1A external-priority patent/GB9605434D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9611511A publication Critical patent/BR9611511A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9611511A 1995-11-16 1996-11-12 Derivados de aminoácidos excitatórios BR9611511A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US686495P 1995-11-16 1995-11-16
GBGB9605434.1A GB9605434D0 (en) 1996-03-15 1996-03-15 Excitatory amino acid derivatives
PCT/US1996/018112 WO1997018199A1 (en) 1995-11-16 1996-11-12 Excitatory amino acid derivatives

Publications (1)

Publication Number Publication Date
BR9611511A true BR9611511A (pt) 1999-05-04

Family

ID=26308935

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611511A BR9611511A (pt) 1995-11-16 1996-11-12 Derivados de aminoácidos excitatórios

Country Status (22)

Country Link
EP (1) EP0774461B1 (pt)
KR (1) KR19990067598A (pt)
CN (1) CN1202167A (pt)
AR (2) AR006748A1 (pt)
AT (1) ATE319685T1 (pt)
AU (1) AU703409B2 (pt)
BR (1) BR9611511A (pt)
CA (1) CA2237910C (pt)
CO (1) CO4770955A1 (pt)
CZ (1) CZ150198A3 (pt)
DE (1) DE69635886T2 (pt)
EA (1) EA001617B1 (pt)
ES (1) ES2258771T3 (pt)
HU (1) HUP9903459A3 (pt)
IL (1) IL124487A (pt)
NO (1) NO982202D0 (pt)
NZ (1) NZ323205A (pt)
PE (1) PE17798A1 (pt)
PL (1) PL326695A1 (pt)
TR (1) TR199800877T2 (pt)
WO (1) WO1997018199A1 (pt)
YU (1) YU60796A (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6248798A (en) * 1997-01-29 1998-08-18 Eli Lilly And Company Treatment for premenstrual dysphoric disorder
US6825211B1 (en) 1997-07-18 2004-11-30 Georgetown University Bicyclic metabotropic glutamate receptor ligands
AU743899B2 (en) 1997-07-18 2002-02-07 Georgetown University Bicyclic metabotropic glutamate receptor ligands
DE19801646A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte alpha,beta-annellierte Butyrolactone
DE19801647A1 (de) * 1998-01-17 1999-07-22 Bayer Ag Substituierte beta,gamma-annellierte Lactone
DE19801648A1 (de) * 1998-01-17 1999-07-22 Bayer Ag alpha-Substituierte Lactone
DE19801636A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte bicyclische Lactone
GB2355982A (en) * 1999-11-03 2001-05-09 Lilly Co Eli Heterocyclic amino acids
TWI315666B (en) * 2002-06-11 2009-10-11 Lilly Co Eli Prodrugs of excitatory amino acids
US8497384B2 (en) 2008-11-14 2013-07-30 Dsm Fine Chemicals Austria Nfg Gmbh & Co Kg Process for the production of cyclopropane derivatives
WO2010111080A2 (en) 2009-03-27 2010-09-30 Eli Lilly And Company Optimized treatment of schizophrenia
US8735397B2 (en) * 2010-03-29 2014-05-27 Vanderbilt University Method for treating schizophrenia and related diseases
SI2721012T1 (sl) 2011-06-17 2016-08-31 Eli Lilly And Company Derivati biciklo(3.1.0)heksan-2,6-dikarboksilne kisline kot agonisti mglu2 receptorja
AR089718A1 (es) 2012-02-01 2014-09-10 Lilly Co Eli AGONISTAS DE mGlu2/3
EA033889B1 (ru) 2014-01-21 2019-12-05 Янссен Фармацевтика Нв Комбинация на основе лиганда sv2a и положительного аллостерического модулятора метаботропного глутаматергического рецептора 2 подтипа
LT3431106T (lt) 2014-01-21 2021-02-10 Janssen Pharmaceutica Nv Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2572842A (en) * 1947-08-05 1951-10-30 Du Pont The n-carboanhydride of 2-amino-4, 6, 6-trimethylheptanoic acid and polymers therefrom
US4536330A (en) * 1982-09-23 1985-08-20 International Flavors & Fragrances Inc. 1-Hydroxymethyl-2-acyl cyclopropane derivatives and esters and cyclic condensation products thereof, organoleptic uses of same and processes for preparing same
PL182285B1 (pl) * 1994-08-12 2001-12-31 Lilly Co Eli Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL
EP0776200A4 (en) * 1994-08-12 2001-01-17 Lilly Co Eli AGENT AND METHOD FOR PROTECTING DRUG ADDICTION
PT776201E (pt) * 1994-08-12 2002-03-28 Lilly Co Eli Composicao e metodo para tratar a ansiedade

Also Published As

Publication number Publication date
PL326695A1 (en) 1998-10-26
IL124487A (en) 2001-01-11
DE69635886D1 (de) 2006-05-04
CN1202167A (zh) 1998-12-16
IL124487A0 (en) 1998-12-06
NZ323205A (en) 1999-06-29
AR006748A1 (es) 1999-09-29
HUP9903459A2 (hu) 2001-04-28
AR004602A1 (es) 1998-12-16
ATE319685T1 (de) 2006-03-15
EP0774461A1 (en) 1997-05-21
CA2237910A1 (en) 1997-05-22
CA2237910C (en) 2005-12-27
NO982202L (no) 1998-05-14
ES2258771T3 (es) 2006-09-01
WO1997018199A1 (en) 1997-05-22
YU60796A (sh) 1998-12-23
EP0774461B1 (en) 2006-03-08
EA199800377A1 (ru) 1998-10-29
AU7727996A (en) 1997-06-05
HUP9903459A3 (en) 2001-08-28
CZ150198A3 (cs) 1998-10-14
CO4770955A1 (es) 1999-04-30
PE17798A1 (es) 1998-04-18
AU703409B2 (en) 1999-03-25
KR19990067598A (ko) 1999-08-25
EA001617B1 (ru) 2001-06-25
DE69635886T2 (de) 2006-10-19
TR199800877T2 (xx) 1998-09-21
NO982202D0 (no) 1998-05-14

Similar Documents

Publication Publication Date Title
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
DK0696577T3 (da) Syntetiske excitatoriske aminosyrer
PT833828E (pt) Derivados de rapamicina
DE122009000076I1 (de) Chinazolin-derivate
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
BR9605434A (pt) Derivados de purin-6-ona
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
BR9611511A (pt) Derivados de aminoácidos excitatórios
BR9611509A (pt) Antagonistas de receptores de aminoácidos excitativos
BR9606814A (pt) Amidas de ácido alcoximinoacético
FI950586A0 (fi) Aminohappojohdos
DE69606053D1 (de) Modifizierte fluorsulfonsäure
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
ATA100695A (de) Prothrombin-derivate
PT856007E (pt) Derivados de ciclopeptidos
BR9609671A (pt) Amino uracilas substituídas
ATE240307T1 (de) Diarylalkenylamin-derivate
ATE202093T1 (de) 4-amino-benzoylguanidin-derivate
DE59610106D1 (de) Fluorbenzylether-Derivate
ATE177102T1 (de) Chromanderivate
EP0850950A4 (en) Peptide derivatives
PT843675E (pt) Derivados de aza-antraciclinona
BR9603508A (pt) Derivados de alquenil-benzoilguanidina
EP0861849A4 (en) PEPTIDE DERIVATIVES
DE59607055D1 (de) 4-Mercapto-benzoylguanidin-Derivate

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time